Popular

• 

  RestartResume

  Albuminuria: An Overlooked Red Flag in Cardiovascular Risk

  Conversations in CV Risk Assessment

  Albuminuria: An Overlooked Red Flag in Cardiovascular Risk

  • 

    

    Matthew Sorrentino, MD

  • 

    

    Ashish Verma, MBBS

• 

  RestartResume

  Anti-Amyloid Therapy in Early Alzheimer’s Disease: Real-World Experience and Innovation 

  Medical Industry Feature

  Anti-Amyloid Therapy in Early Alzheimer’s Disease: Real-World Experience and Innovation 

  • 

    

    Marwan Sabbagh, MD, FAAN, CCR

  • 

    

    Cara Leahy, DO

  • 

    

    David Weisman, MD

• 

  RestartResume

  Agitation in Alzheimer’s Dementia: From Expert Consensus to Clinical Practice

  Medical Industry Feature

  Agitation in Alzheimer’s Dementia: From Expert Consensus to Clinical Practice

  • 

    

    Charles Turck, PharmD, BCPS, BCCCP

  • 

    

    George Grossberg, MD

  • 

    

    Angela Sanford, MD, CMD

• 

  RestartResume

  Overcoming Vaccine Hesitancy: Persuasive Conversation Strategies and Tips

  Medical Industry Feature

  Overcoming Vaccine Hesitancy: Persuasive Conversation Strategies and Tips

• 

  RestartResume

  Advancing Care in ER+/HER2− ESR1m mBC: What EMERALD and Real-World Analyses Tell Us

  Medical Industry Feature

  Advancing Care in ER+/HER2− ESR1m mBC: What EMERALD and Real-World Analyses Tell Us

  • 

    

    Jennifer Caudle, DO, FACOFP

  • 

    

    Seth Wander, MD, PhD

• 

  RestartResume

  Bridging the Gap in AYA Cure Rates

  Medical Industry Feature

  Bridging the Gap in AYA Cure Rates

  • 

    

    Ibrahim Aldoss, MD

• 

  RestartResume

  Breakthrough Technology Improves Concussion Assessment and Player Safety

  Medical Industry Feature

  Breakthrough Technology Improves Concussion Assessment and Player Safety

  • 

    

    Thomas S. Bottiglieri, DO

• 

  RestartResume

  Hidden High Risk: When BP Control Isn’t Enough in Hypertension

  Conversations in CV Risk Assessment

  Hidden High Risk: When BP Control Isn’t Enough in Hypertension

  • 

    

    Gates B. Colbert, MD

  • 

    

    Michael E. Hall, MD

  • 

    

    Clyde W. Yancy, MD

• 

  RestartResume

  Rethinking Cardiovascular Risk: Uncovering the Blind Spots

  Conversations in CV Risk Assessment

  Rethinking Cardiovascular Risk: Uncovering the Blind Spots

  • 

    

    Jennifer Caudle, DO, FACOFP

  • 

    

    Javed Butler, MD, MPH, MBA

• 

  RestartResume

  Elevating CV Risk Assessment: Why uACR Deserves a Seat at the Table

  Conversations in CV Risk Assessment

  Elevating CV Risk Assessment: Why uACR Deserves a Seat at the Table

  • 

    

    Brian P. McDonough, MD, FAAFP

  • 

    

    Javier Morales, MD, FACP, FACE

• 

  RestartResume

  Research Uncovers a Potential Biomarker for Postpartum Depression Risk

  Medical Industry Feature

  Research Uncovers a Potential Biomarker for Postpartum Depression Risk

  • 

    

    Lauren Osborne, M.D.

• 

  RestartResume

  Treating Mild Cognitive Impairment in Alzheimer’s Disease: A Therapy’s 2-Way MOA

  Medical Industry Feature

  Treating Mild Cognitive Impairment in Alzheimer’s Disease: A Therapy’s 2-Way MOA

• 

  RestartResume

  Targeting Neutrophilic Inflammation in Bronchiectasis: An Emerging Approach

  Medical Industry Feature

  Targeting Neutrophilic Inflammation in Bronchiectasis: An Emerging Approach

• 

  RestartResume

  Living with Psoriatic Arthritis: A Doctor-Patient Conversation

  Medical Industry Feature

  Living with Psoriatic Arthritis: A Doctor-Patient Conversation

  • 

    

    Elizabeth Perkins, MD

  • 

    

    Dawn Carter

• 

  RestartResume

  ReDiscover-2: Currently Enrolling Patients With PIK3CA-Mutated Advanced Breast Cancer

  Medical Industry Feature

  ReDiscover-2: Currently Enrolling Patients With PIK3CA-Mutated Advanced Breast Cancer

  • 

    

    Charles Turck, PharmD, BCPS, BCCCP

  • 

    

    Sarah Sammons, MD